Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Adagene Inc.ADAG · Entity 6155 | Director | August 13, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Adagene Inc.
Report date August 13, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Nonqualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2036-08-13 | Direct | 90,000 |
Reported balance
After 2026-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-13 · Grant · Acquired 20,000 · Balance 90,000 F1: 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier. |
Filing footnotes · ownership attribution and instrument terms
F1: 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2026 Filed Aug 18, 2026 00:30 UTC | Adagene Inc. ADAG · Entity 6155 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001104659-26-097995 · tm2623261-1_4seq1.xml · derivative · entry 1 Cheung Andy Yiu Leung · CIK 0002110863 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Ordinary Shares · 20,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.